Luer New Materials

Luer New Materials (鲁尔新材) is a phase-change materials company founded in 2011, positioned as a platform-type service provider focused on temperature control through phase-change materials combined with digital technology . The company first solved pain points in pharmaceutical cold-chain logistics and counts Sinovac, MSD, Eli Lilly, Roche, Johnson & Johnson, Sinopharm, JD.com, and SF Express among its customers . Its temperature-control technology spans arbitrary ranges between -80°C and 100°C, with material forms evolving from solid-liquid to liquid-liquid and solid-solid, applied across pharmaceuticals, fresh food, carbon neutrality, heat dissipation, industrial applications, and building energy efficiency . Linear Capital led Luer's Series A round in 2021 and increased its stake in a subsequent A++ round of tens of millions of RMB closed by September 2022, with Puhua Capital leading that round . Founder and chairman Zhi Xiaohua holds a PhD in organic chemistry from a joint program between the Chinese Academy of Sciences' Institute of Chemistry and Germany's Fraunhofer Institute, and the company benchmarked itself against German industry standards from the start .